Delivery Order SPE2DR25D3103-SPE2DR26F9F39
Award Date 11/13/25
Potential Completion Date 11/14/25
Potential Value $12K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency awarded a $5,684.52 delivery order to AmerisourceBergen Drug Corp for the supply of Kanjinti 420 mg vials, with an ultimate completion date of September 4, 2025. This contract represents a firm fixed-price delivery order with no set-aside designation, awarded competitively on September 3, 2025. The product will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is a child contract issued under...
- The Defense Logistics Agency awarded a delivery order valued at $9,474.20 to AmerisourceBergen Drug Corp for Kanjinti 420 mg vials, with a completion date of June 6, 2025. This non-competitive delivery order was issued under a firm fixed-price contract structure and will be performed at the contractor's facility in Conshohocken, Pennsylvania. Kanjinti is a biosimilar trastuzumab used in oncology treatment, reflecting the pharmaceutical distributor's role in supplying specialized medications to...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp's Corporate Office Division, a major pharmaceutical distributor, for the supply of KANJINTI 420 MG VIALS. The firm-fixed-price contract has a ceiling value of $14,564.76 and a completion date of May 10, 2024. AmerisourceBergen, a subsidiary of Cencora, Inc., holds a significant Indefinite Delivery Contract (IDC) with DLA Troop Support Medical worth up to $999,999,999.00 through December 2025,...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a subsidiary of Cencora, Inc., for the supply of the pharmaceutical product KANJINTI 420 MG VIALS. The contract has a ceiling value of $56,057.30 and runs through September 1, 2021. The contract was awarded on August 31, 2021 and is a firm-fixed-price contract. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
- This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corporation's Corporate Office Division. The contract is for the supply of 4,565,402,851 units of the pharmaceutical product KANJINTI 420 MG VIALS. The contract is a firm-fixed price award with a ceiling value of $14,730.10 and an ultimate completion date of August 12, 2024. Amerisourcebergen, a major pharmaceutical distributor, has been awarded this contract to...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp's Corporate Office division. The $31,672.20 fixed-price contract is for the supply of 420 mg vials of the oncology medication Kanjinti. The contract has an ultimate completion date of August 22, 2024. AmerisourceBergen, a large pharmaceutical distributor, has been awarded multiple indefinite delivery contracts (IDCs) with the DLA and other federal agencies to provide a wide...
- This federal contract award was made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $10,557.40 firm fixed-price delivery order is for the procurement of KANJINTI 420 MG VIALS, a specialty pharmaceutical product. The award does not have a set-aside designation, indicating open competition. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA), a defense agency, to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of 420 mg vials of the drug KANJINTI. The contract has a firm fixed price of $18,948.40 and a completion date of June 26, 2025. The contract is not set aside and represents an open competition. AmerisourceBergen Drug Corp holds a larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at...
- The Defense Logistics Agency awarded a Delivery Order (4569006087) valued at $8,888.50 to AmerisourceBergen Drug Corp for the supply of Enhertu 100 mg vials, with a completion date of August 27, 2025. This is a firm fixed price, competitively awarded contract with no set-aside designation. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, fulfills this order from its corporate office location. The company serves as a critical vendor...
- The Defense Logistics Agency (DLA) awarded a delivery order contract valued at $39,474.69 to AmerisourceBergen Drug Corp for TNKASE 50 MG kits on October 16, 2025, with completion scheduled for October 17, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The contract represents a child award under AmerisourceBergen's broader Indefinite Delivery...